Thomas Tillett
Fondateur chez MBF Therapeutics, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Barbara E. Thalenfeld | M | 84 |
American Society of Gene Therapy
| - |
| Barrie J. Carter | M | 79 |
American Society of Gene Therapy
| - |
| Sherry Grisewood | F | 71 |
American Society of Gene Therapy
| - |
| Ian MacLachlan | M | - |
American Society of Gene Therapy
| - |
| Jon A. Wolff | M | - |
American Society of Gene Therapy
| - |
| Joy A. Cavagnaro | M | - |
American Society of Gene Therapy
| - |
| Christopher Michael Cashman | M | 67 |
MBF Therapeutics, Inc.
 MBF Therapeutics, Inc. Agricultural Commodities/MillingProcess Industries MBF Therapeutics, Inc. develops and provides veterinary oncology products. It develops and commercializes proprietary checkpoint inhibitor immunotherapy technology based on vaccines and vaccine adjuvants. The company was founded by Thomas Tillett and Travis Meredith in 2008 and is headquartered in Ambler, PA. | - |
| Robert Lawrence Martuza | M | 75 |
American Society of Gene Therapy
| - |
| Douglas J. Jolly | M | - |
American Society of Gene Therapy
| - |
| Lorraine H. Keller | M | - |
MBF Therapeutics, Inc.
MBF Therapeutics, Inc. Agricultural Commodities/MillingProcess Industries MBF Therapeutics, Inc. develops and provides veterinary oncology products. It develops and commercializes proprietary checkpoint inhibitor immunotherapy technology based on vaccines and vaccine adjuvants. The company was founded by Thomas Tillett and Travis Meredith in 2008 and is headquartered in Ambler, PA. | - |
| Debabrata Banerjee | M | 66 |
American Society of Gene Therapy
| - |
| Giuseppe Ciaramella | M | 55 |
American Society of Gene Therapy
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Travis Meredith | M | - |
MBF Therapeutics, Inc.
MBF Therapeutics, Inc. Agricultural Commodities/MillingProcess Industries MBF Therapeutics, Inc. develops and provides veterinary oncology products. It develops and commercializes proprietary checkpoint inhibitor immunotherapy technology based on vaccines and vaccine adjuvants. The company was founded by Thomas Tillett and Travis Meredith in 2008 and is headquartered in Ambler, PA. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 13 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Thomas Tillett
- Réseau Personnel
